Literature DB >> 413843

Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.

E T Houang, D Greenwood.   

Abstract

Ten strains each of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa were habituated to gentamicin by serial passage in antibiotic containing medium. Complete cross-resistance to streptomycin, neomycin, kanamycin, and tobramycin in a linear proportional fashion was demonstrated at all stages of habituation. Most strains of Staph. aureus and Ps. aeruginosa showed a greater increase in resistance to gentamicin than to the other three aminoglycosides. E. coli required more transfers to reach the same degree of resistance than did the other two species. Reversion to greater susceptibility to gentamicin took place after serial passage on antibiotic-free media. 'Wild' gentamicin-resistant strains showed no such proportionality of resistance to kanamycin, neomycin, or streptomycin. But many of these strains showed a proportional increase in resistance to tobramycin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 413843      PMCID: PMC476537          DOI: 10.1136/jcp.30.8.738

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin.

Authors:  C M KUNIN; C WILCOX; A NAJARIAN; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1958-11

2.  Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.

Authors:  D Greenwood
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.

Authors:  D Greenwood; F O'Grady
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

Review 4.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

5.  Surface lipid of cells of Pseudomonas aeruginosa and its relation to gentamicin-resistance.

Authors:  D T Pechey; A M James
Journal:  Biomedicine       Date:  1973-04-10

6.  Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity.

Authors:  J Klastersky; D Daneau; V de Maertelaer
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

7.  In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.

Authors:  B Wretland; C E Nord; T Wadström
Journal:  Scand J Infect Dis       Date:  1974

8.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

9.  R factors in gentamicin-resistant organisms causing hospital infection.

Authors:  A S Richmond; M S Simberkoff; J J Rahal; S Schaefler
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

10.  Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance.

Authors:  G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

View more
  8 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Antibiotic production improvement in the rare actinomycete Planobispora rosea by selection of mutants resistant to the aminoglycosides streptomycin and gentamycin and to rifamycin.

Authors:  Fabrizio Beltrametti; Roberta Rossi; Enrico Selva; Flavia Marinelli
Journal:  J Ind Microbiol Biotechnol       Date:  2005-12-06       Impact factor: 3.346

3.  Specific and non-specific resistance to aminoglycosides in Escherichia coli.

Authors:  S L Mawer; D Greenwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

Review 4.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Regrowth of aminoglycoside-resistant variants and its possible implication for determination of MICs.

Authors:  L Sörén; L Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

6.  Characteristics of Pseudomonas aeruginosa in relation to laboratory-induced resistance to gentamicin.

Authors:  G Dimitracopoulos; C Intzes; J Papavassiliou
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

7.  The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.

Authors:  Emma Myhrman; Joakim Håkansson; Kerstin Lindgren; Camilla Björn; Veronika Sjöstrand; Margit Mahlapuu
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-04       Impact factor: 4.813

8.  Antibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, Malaysia.

Authors:  Mainul Haque; Nor Iza A Rahman; Zainal Zulkifli; Salwani Ismail
Journal:  Ther Clin Risk Manag       Date:  2016-03-12       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.